Has Patrick Rowan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,701 in general payments to Patrick Rowan, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Patrick Rowan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Patrick Rowan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Patrick Rowan, MD

Forensic Psychiatry · Brooklyn, NYNPI 1316090087

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by CGG Medical Inc at 32.2% of the total. Reporting peaked in 2022 at $544 and has fallen 70.5% since, to $160 in 2025. Among forensic psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,701in general payments, 2019–2025

Across 57 payments — averaging $29.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CGG Medical Inc$547
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$492
Otsuka America Pharmaceutical, Inc.$161
Johnson & Johnson$111
Neurocrine Biosciences, Inc.$80
Harmony Biosciences LLC$67
plus $243 from 6 others

What the payments were for

Food & beverage$1,701100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CGG Medical Inc	4	$547
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	18	$492
Otsuka America Pharmaceutical, Inc.	4	$161
Johnson & Johnson	7	$111
Neurocrine Biosciences, Inc.	5	$80
Harmony Biosciences LLC	4	$67
Bausch Health US, LLC	4	$60
AbbVie	3	$57
Teva Pharmaceuticals USA, Inc.	3	$40
Novo Nordisk	2	$39
Lilly USA, LLC	2	$33
Axsome Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REXULTI$120
CAPLYTA$105

How this compares

$1,701 in reported general payments places this provider in the 90th percentile of 27 forensic psychiatry providers in New York.

See all forensic psychiatry providers in New York →

Medicare billing

Part B allowed, 2024

$20,434

Medicare patients

Services billed

144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Duloxetine Hcl	62	$1,077
Divalproex Sodium	42	$928
Paroxetine Hcl	66	$612
Bupropion XlBupropion Hcl	54	$603
Trazodone Hcl	125	$602
Venlafaxine Hcl ErVenlafaxine Hcl	57	$562
Quetiapine Fumarate	35	$528
Gabapentin	34	$427
Naltrexone Hcl	13	$425
Vilazodone Hcl	15	$390
Aripiprazole	18	$371
Ziprasidone Hcl	24	$370
Escitalopram Oxalate	50	$362
Clonazepam	58	$324
Zolpidem Tartrate ErZolpidem Tartrate	13	$239

Paid to pharmacies, not to this prescriber.

Other forensic psychiatry in Brooklyn

Jason HershbergerBrooklyn$8K
Steven KonradBrooklyn$320
Martin DrookerNew York$2K
Tina KrishnaraoNew York$1K
Joel IdowuStaten Island$947
Richard WangNew Hampton$791
James HicksNew York$637
Marc LibmanRochester$548
Odysseus AdamidesLyons$460
Lawrence SiegelBronx$343

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →